Billions of euros are wasted ever year on research that is redundant, flawed, never published or poorly reported.
Long-term outcomes of NEuroSIS study published in New England Journal of Medicine
The FP7 funded project Neonatal European Study of Inhaled Steroids (NEuroSIS) is a randomized, placebo-controlled international multicentre clinical trial and focuses on preterm infants born at less than 28 weeks of gestational age and the main objective was to determine whether the early inhalation of budesonide reduces the risk of mortality and bronchopulmonary dysplasia. The results of NEuroSIS provided useful indications about the efficacy and safety of inhaled steroids in very preterm infants. Today, NEuroSIS has published an article on long-term effects of inhaled budesonide for bronchopulmonary dysplasia in the New England Journal of Medicine.
Juncker Plan supports cancer research with €40 million loan to Indivumed
The European Investment Bank is providing a loan of €40 million to Indivumed GmbH. The new funding will allow this German company to continue its development of a global database, supporting the work of cancer researchers by providing access to data from cancer patients, as well as investing in the latest technology to better understand complex cancer data. The financing for this project is guaranteed by the European Fund for Strategic Investments, the central pillar of the Investment Plan for Europe.
- Press release
- Indivumed project
- Investment Plan for Europe: the Juncker Plan
- European Fund for Strategic Investments
Launch of the Public Consultation on Vaccination – have your say!
Today, the European Commission is officially launching the Public Consultation on strengthened cooperation against vaccine preventable diseases. The objectives of the consultation will be to collect views from the general public and stakeholders on three main aspects of vaccination: addressing vaccine hesitancy and improving vaccination coverage, achieving sustainable vaccine policies in the EU and improving EU coordination, promoting stakeholders dialogue and contributing to global health. Vaccination is the main tool for primary prevention of disease. Misconceptions about vaccination have shifted the public focus away from the individual and collective benefits of vaccination to increased distrust of science and fear of possible side effects.
EU-funded project BATCure to tackle the Batten disease
Batten disease is a fatal, inherited disorder of the nervous system that typically begins in childhood. The goal of Horizon 2020 project BATCure is to advance the development of new therapeutic options for a group of rare lysosomal diseases or Batten disease. The project aims to create new models, tools and technologies for developing and testing therapies.
EU-funded project U-PGx wants to make treatment optimization accessible to everyone
The U-PGx consortium addresses major challenges and obstacles for implementation of PGx testing in patient care, taking into account the diversity of healthcare systems and citizens across Europe. Specifically, U-PGx will investigate if the emerging approach of pre-emptive genotyping of an entire panel of important PGx markers is cost-effective and results in a better outcome for patients. The project combines existing pharmacogenomics guidelines and novel health IT solutions.
Health Info Day 2017 – presentations available now
In the framework of the Health Info Day, the Horizon 2020 Work Programme 2018-2020 for Societal Challenge 1 was presented and the participants were informed about the topics, deadlines and process of the next calls for proposals. All presentations and video recording are now online.
30 January 2018, Brussels, Belgium - Message from Alliance4Life
15-16 March 2018, Düsseldorf, Germany - Successful R&I in Europe 2018 - 9th European Networking Event